Brief: Ulisse Biomed Sees 2028 EBITDA Between EUR 0.5-0.8 Mln

Helyx Industries SpA

12/12/2024 06:19

Dec 12 (Reuters) - Ulisse Biomed SpA  UBM.MI :
    * REPORTED ON WEDNESDAY PRELIM 2024 REVENUE AT AROUND EUR 1
MLN
    * 2024 EBITDA AT AROUND NEGATIVE EUR 2.2 MLN
    * SEES 2025 REVENUES BETWEEN EUR 1.4-1.6 MLN
    * SEES 2025 EBITDA NEGATIVE BETWEEN EUR 0.6-0.4 MLN
    * SEES 2028 REVENUES BETWEEN EUR 2.8-3.5 MLN
    * SEES 2028 EBITDA BETWEEN EUR 0.5-0.8 MLN

 Further company coverage:  UBM.MI  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))